Akèy › Ensifizyans kadyak › Massachusetts › Boston
Etid klinik pou Ensifizyans kadyak nan Boston, MA
44 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
ELEVATE-HFpEF Clinical Study
Ap rekrite
- Tufts Medical Center, Boston
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Ap rekriteFaz 3
- Research Site, Boston
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Ap rekrite
- Boston Medical Center, Boston
Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Mass General Brigham, Boston
HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Mass General Brigham, Boston
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Ap rekriteFaz 3
- Research Site, Boston
- Research Site, Boston
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Ap rekriteFaz 3
- Tufts Medical Center, Boston
Alleviant ALLAY-HFrEF Study
Ap rekrite
- Tufts Medical Center, Boston
- Brigham and Women's Hospital, Boston
- Boston Medical Center, Boston
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Ap rekriteFaz 3
- Research Site, Boston
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Ap rekriteFaz 3
- Boston, MA Investigative Stie 10087, Boston
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Ap rekrite
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
Ap rekrite
- Massachusetts General Hospital, Boston
Targeted Artificial Intelligence Language mOdel Recommendations for Heart Failure (TAILOR-HF)
Ap rekrite
- Mass General Brigham, Boston
Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Massachusetts General Hospital, Boston
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Ap rekriteFaz 2/3
- Boston Children's Hospital ( Site 0035), Boston
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Ap rekriteFaz 2
- Massachusetts General Hospital, Boston
Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM
Ap rekriteEtid obsèvasyon
- Research Site, Boston
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Ap rekriteEtid obsèvasyon
- Boston, Boston
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Ap rekriteEtid obsèvasyon
- Harvard (Massachusetts General Hospital), Boston
- Harvard Medical School - Brigham and Women's Hospital (BWH), Boston
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Ap rekriteFaz 3
- Tenax Investigational Site, Boston
Alleviant ALLAY-HF Study
Ap rekrite
- Brigham and Women's Hospital, Boston
- Boston Medical Center, Boston
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
Ap rekriteEtid obsèvasyon
- Tufts Medical Center, Boston
Assessment of CCM in HF With Higher Ejection Fraction
Ap rekrite
- Massachusetts General Hospital, Boston
Care Transitions App for Patients With Multiple Chronic Conditions
Ap rekriteVolontè an sante akeyi
- Brigham and Women's Hospital, Boston
The STOP-MED CTRCD Trial
Ap rekriteFaz 4
- Brigham and Women's Hospital, Boston
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Ap rekriteFaz 3
- Boston Children's Hospital - Main Campus - Cardiology, Boston
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Ap rekrite
- Tufts Medical Center, Boston
- Boston Medical Center Corporation, Boston
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Ap rekriteFaz 3
- Boston Children's Hospital - Main Campus - Cardiology, Boston
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Ap rekrite
- Massachusetts General Hospital, Boston
CCM OPEN HF Registry
Ap rekriteEtid obsèvasyon
- Massachusetts General Hospital, Boston
Promoting Well-being and Health in Heart Failure
Ap rekrite
- Massachusetts General Hospital, Boston
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Ap rekrite
- St Elizabeth's Medical Center, Boston
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess, Boston
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Ap rekriteFaz 3
- Joslin Diabetes Center, Boston
Home Hospital for Suddenly Ill Adults
Ap rekrite
- Brigham and Women's Hospital, Boston
- Brigham and Women's Faulkner Hospital, Boston
Diffusion MRI in Heart Failure
Ap rekriteFaz 1 bonèVolontè an sante akeyi
- Massachusetts General Hospital, Charlestown · 1 mi lwen
A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart Failure
Ap rekrite
- Tufts Medical Center, Boston
Pulmonary Artery Catheter in Cardiogenic Shock Trial
Ap rekrite
- Tufts Medical Center, Boston
US Benchmarking Clinical Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
- Boston Medical Center, Boston
Left vs Left Randomized Clinical Trial
Ap rekrite
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
Cardiogenic Shock Working Group Registry
Ap rekriteEtid obsèvasyon
- Tufts Medical Center, Boston
- Beth Israel Deaconess Medical Center, Boston
A Multi-center, National, Open-label, Prospective Study to Evaluate the Performance of the V-Lap™ System
Ap rekrite
- One Boston Medical Center Place, Boston
Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
Ap rekriteEtid obsèvasyon
- Tufts Medical Center, Boston
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
Ap rekriteFaz 1
- Brigham and Women's Hospital, Boston
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Ap rekriteEtid obsèvasyon
- Brigham and Women's Hospital, Boston
Etid Ensifizyans kadyak nan lòt vil
- New York City, NY51 etid
- Dallas, TX42 etid
- Houston, TX36 etid
- Cleveland, OH33 etid
- Chicago, IL31 etid
- Philadelphia, PA31 etid
- San Francisco, CA29 etid
- St. Louis, MO26 etid
- Durham, NC26 etid
- Kansas City, MO25 etid
- Atlanta, GA25 etid
- Baltimore, MD24 etid
Lòt etid nan Boston
- Kansè nan tete111 etid
- Kansè Poumon ki pa ti selil90 etid
- Kansè (tout kalite)86 etid
- Kansè kolorektal63 etid
- Kansè Metastatik63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat59 etid
- Depresyon52 etid
- Kansè Endomèt50 etid
- Leksemi mieloïd egi44 etid
- Kansè pankreyas43 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.